Log In or Register to Join The Conversation!

This topic is empty.

  • Author
    Posts
    • #24817
      Kevin Schaefer
      Keymaster

      Happy Thursday!

      Check out the latest podcast here. In this episode, Michael and I discuss news regarding the FDA-approved treatment Evrysdi, and Michael’s decision to switch to this therapy. We also talk about the clinical trial drug SRK-015, which is developed by Scholar Rock. Finally, I read excerpts from some of our recent columns. 

      Hope you enjoy listening!

      Do you have any takeaways from this episode? Any questions regarding Evrysdi or SRK-015?

Viewing 0 reply threads
  • You must be logged in to reply to this topic.

©2020 KLEO Template a premium and multipurpose theme from Seventh Queen

CONTACT US

We're not around right now. But you can send us an email and we'll get back to you, asap.

Sending
or

Log in with your credentials

or    

Forgot your details?

or

Create Account

Copyright © 2017-2020 All rights reserved.